Revelation Biosciences (REVB) Earnings Analysis

Revelation Biosciences (REVB) next reports earnings on 2026-08-07, consensus EPS -0.83 USD. Last quarter (2026-05-07) it missed with EPS -2.71 USD vs -1.15 USD est (-135.7%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -0.09.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does REVB next report earnings?

Next earnings date2026-08-07
Consensus EPS estimate-0.83 USD
Revenue estimaten/a

REVB earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-2.71 USD-1.15 USD-135.7%Miss
2026-02-26-1.65 USD-3.66 USD+54.9%Beat
2025-11-06-7.08 USD-5.36 USD-32.1%Miss
2025-08-07-7.01 USD-4.46 USD-57.2%Miss
2025-05-08-6.33 USD-20.64 USD+69.3%Beat
2025-03-06-14.94 USD-9.6 USD-55.6%Miss
2024-11-08-40.32 USD-136.33 USD+70.4%Beat
2024-08-09-73.93 USD-86.89 USD+14.9%Beat

Beat rate: 4/8 (50%) over reported quarters with consensus data.

REVB valuation and analyst view

Trailing P/E-0.09
Trailing EPS-3.07746 USD
Price / book0.28
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Revelation Biosciences (REVB)'s next earnings date?

Revelation Biosciences is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -0.83 USD.

Did REVB beat earnings last quarter?

In its 2026-05-07 report, REVB posted EPS of -2.71 USD versus a -1.15 USD estimate — a miss of 135.7%.

What is REVB's earnings track record?

Over the last 8 reported quarters with consensus data, REVB beat estimates 4 times (50%).

What is REVB's current P/E ratio and EPS?

REVB trades at a trailing P/E of -0.09 on trailing EPS of -3.077455326524759 USD.

What do analysts rate REVB?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).